Latest News
DataMEDS AI, Inc.
- Datavault AI signs letter of intent for 19.9% stake in DataMEDS
- Datavault AI signs LOI to acquire 19.9% stake in DataMEDS AI
- DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
- DataMEDS AI, Inc. (MEDS) Restates LOI to License/Acquire Telehealth, Drone and Data IP
- Form 8K DataMeds AI Inc For: 20 October By Investing.com
- DataMeds AI, Inc. (MEDS) Regains Nasdaq Equity Compliance
- DataMeds AI Secures Exclusive U.S. License to REBOOT AI Platform; Issues $2M in Stock
- DataMeds AI Enters IP License Agreement With Reboot Health AI
- DataMeds AI, Inc. (MEDS) Maps Strategy for FDA’s Proposed Peptide Policy
- DataMeds AI, Inc. (MEDS) Licenses Exclusive U.S. DTC GLP-1 Platform
- DataMeds AI settles disputes, repurchases shares and issues stock in tech license deal
- DataMeds AI, Inc. (MEDS) Cuts Costs, Focuses on ChemoFx After Helomics Deal
Headlines from the last 30 days, linking to the original publishers. See all market news →